...
首页> 外文期刊>Human Molecular Genetics >A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E
【24h】

A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E

机译:顺式调节位点下调易位t(8; 12)(q13; p11.2)中的PTHLH,并导致近距离E型

获取原文

摘要

Parathyroid hormone-like hormone (PTHLH) is an important chondrogenic regulator; however, the gene has not been directly linked to human disease. We studied a family with autosomal-dominant Brachydactyly Type E (BDE) and identified a t(8;12)(q13;p11.2) translocation with breakpoints (BPs) upstream of PTHLH on chromosome 12p11.2 and a disrupted KCNB2 on 8q13. We sequenced the BPs and identified a highly conserved Activator protein 1 (AP-1) motif on 12p11.2, together with a C-ets-1 motif translocated from 8q13. AP-1 and C-ets-1 bound in vitro and in vivo at the derivative chromosome 8 breakpoint [der(8) BP], but were differently enriched between the wild-type and BP allele. We differentiated fibroblasts from BDE patients into chondrogenic cells and found that PTHLH and its targets, ADAMTS-7 and ADAMTS-12 were downregulated along with impaired chondrogenic differentiation. We next used human and murine chondrocytes and observed that the AP-1 motif stimulated, whereas der(8) BP or C-ets-1 decreased, PTHLH promoter activity. These results are the first to identify a cis-directed PTHLH downregulation as primary cause of human chondrodysplasia.
机译:甲状旁腺激素样激素(PTHLH)是重要的软骨生成调节剂。然而,该基因尚未与人类疾病直接相关。我们研究了常染色体显性E型(BDE)常染色体显性家族,并鉴定了在染色体12p11.2上的PTHLH上游具有断点(BP)的t(8; 12)(q13; p11.2)易位和在8q13处的KCNB2断裂。我们对BP进行了测序,并在12p11.2上鉴定了高度保守的激活蛋白1(AP-1)基序,以及从8q13处转移的C-ets-1基序。 AP-1和C-ets-1在衍生染色体8断裂点[der(8)BP]处在体内和体外结合,但在野生型和BP等位基因之间富集程度不同。我们将BDE患者的成纤维细胞分化为软骨细胞,发现PTHLH及其靶标ADAMTS-7和ADAMTS-12随着软骨分化的受损而被下调。接下来,我们使用人和鼠软骨细胞,观察到AP-1基序被刺激,而der(8)BP或C-ets-1降低了PTHLH启动子活性。这些结果是第一个将顺式PTHLH下调鉴定为人类软骨发育不良的主要原因。

著录项

  • 来源
    《Human Molecular Genetics 》 |2010年第5期| p.848-860| 共13页
  • 作者单位

    Department of Genetics, Nephrology, Hypertension, and Vascular Injury, Max-Delbrück Center for Molecular Medicine (MDC), Robert-Rössle Strasse 10, 13125 Berlin, Germany,;

    Department Animal Genetics, Wageningen University, Marijkeweg 40, 6709PG Wageningen, Netherlands,;

    Department of Genetics, Nephrology, Hypertension, and Vascular Injury, Max-Delbrück Center for Molecular Medicine (MDC), Robert-Rössle Strasse 10, 13125 Berlin, Germany,;

    Institute of Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University, Fetscherstrasse 74, 01307 Dresden, Germany,;

    Development and Disease Group, Max-Planck Institute for Molecular Genetics, Ihnestrasse 73, 14195 Berlin, Germany,;

    Institute of Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University, Fetscherstrasse 74, 01307 Dresden, Germany,;

    Hospital for Special Surgery, Laboratory for Cartilage Biology, Weill Cornell Medical College, Caspary Research Building, 535 E. 70th Street, New York, NY 10021, USA and;

    Hospital for Special Surgery, Laboratory for Cartilage Biology, Weill Cornell Medical College, Caspary Research Building, 535 E. 70th Street, New York, NY 10021, USA and;

    Hospital for Special Surgery, Laboratory for Cartilage Biology, Weill Cornell Medical College, Caspary Research Building, 535 E. 70th Street, New York, NY 10021, USA and;

    Department of Genetics, Nephrology, Hypertension, and Vascular Injury, Max-Delbrück Center for Molecular Medicine (MDC), Robert-Rössle Strasse 10, 13125 Berlin, Germany,|Experimental and Clinical Research Center (ECRC), Charité-Universitätsmedizin Berlin, Lindenbergerweg 80, 13125 Berlin, Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号